BBHC
BNTX icon

Brown Brothers Harriman & Co’s BioNTech BNTX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,000
Closed -$241K – 1426
2024
Q2 		$241K Hold
3,000
– – ﹤0.01% 510
2024
Q1 		$277K Buy
3,000
+2,993
+42,757% +$287K ﹤0.01% 466
2023
Q4 		$739 Buy
+7
New +$705 ﹤0.01% 1101

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Brothers Harriman & Co's BNTX Position: Q3 2024 in Review

Brown Brothers Harriman & Co sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 3,000 shares — an estimated $241K sold.

Brown Brothers Harriman & Co first reported a position in BNTX in Q4 2023 and held it in 3 quarters. The position peaked at $277K in Q1 2024. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Brown Brothers Harriman & Co reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 3,000 BioNTech shares in Q3 2024, an estimated $241K.
  • Brown Brothers Harriman & Co first reported a position in BioNTech in Q4 2023 and held it in 3 quarters.
  • Brown Brothers Harriman & Co's BioNTech position peaked at $277K in Q1 2024.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2024, filed 13 Nov 2024.